We are live on ! Find out more
GCM

Goldman Capital Management Portfolio holdings

AUM $103M
1-Year Est. Return 21.37%
This Fund
S&P 500
This Quarter Est. Return
-6.92%
1 Year Est. Return
+21.37%
3 Year Est. Return
+24.28%
5 Year Est. Return
10 Year Est. Return
AUM
$199M
AUM Growth
-$2.03M
Cap. Flow
+$6.59M
Cap. Flow %
3.31%
Top 10 Hldgs %
82.99%
Holding
35
New
3
Increased
15
Reduced
9
Closed
2

Sector Composition

Rank Sector Weight
1 Technology 15.13%
2 Consumer Discretionary 13.74%
3 Communication Services 5.87%
4 Healthcare 4.45%
5 Energy 3.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IW
1
DELISTED
IMAGEWARE SYSTEMS,INC
IW
$74M 37.11%
34,747,610
+181,400
+0.5% +$386K
CTHR
2
DELISTED
Charles & Colvard Ltd
CTHR
$22.4M 11.22%
139,690
HILL
3
DELISTED
DOT HILL SYSTEMS CORP
HILL
$16M 8.01%
4,228,317
-245,000
-5% -$959K
STGW icon
4
Stagwell
STGW
$1.84B
$9.48M 4.75%
493,850
+19,150
+4% +$403K
REFR icon
5
Research Frontiers
REFR
$16.1M
$9.29M 4.66%
1,615,089
+100,651
+7% +$529K
TRAK icon
6
ReposiTrak
TRAK
$148M
$8.49M 4.26%
860,800
-1,000
-0.1% -$10.6K
MATR
7
DELISTED
Mattersight Corp.
MATR
$7.58M 3.8%
1,400,400
+179,044
+15% +$923K
WLB
8
DELISTED
Westmoreland Coal Company
WLB
$6.6M 3.31%
176,300
-4,000
-2% -$163K
LOCM
9
DELISTED
LOCAL CORP COM STK (DE)
LOCM
$6.07M 3.04%
3,035,700
TRIB
10
Trinity Biotech
TRIB
$5.7M
$5.65M 2.83%
2,062
+31
+2% +$101K
LCUT icon
11
Lifetime Brands
LCUT
$198M
$5.03M 2.52%
328,219
-66,438
-17% -$1.12M
PRSO icon
12
Peraso
PRSO
$10.3M
$3.79M 1.9%
196
-4
-2% -$95K
ACTA
13
DELISTED
Actua Corp
ACTA
$3.38M 1.69%
210,700
CYRN
14
DELISTED
CYREN Ltd.
CYRN
$2.99M 1.5%
68,300
+32,050
+88% +$1.56M
CXDO icon
15
Crexendo
CXDO
$215M
$2.23M 1.12%
755,193
+7,624
+1% +$23.5K
XTNT icon
16
Xtant Medical Holdings
XTNT
$60.1M
$2.13M 1.07%
39,683
+22,266
+128% +$1.48M
FCRE
17
DELISTED
FC Global Realty Incorporated Common Stock
FCRE
$1.97M 0.99%
63,373
-62,114
-49% -$2.89M
RCPI
18
DELISTED
ROCK CREEK PHARMACEUTICALS INC COM STK (DE)
RCPI
$1.54M 0.77%
219,420
-4,604
-2% -$45.5K
PSTV icon
19
Plus Therapeutics
PSTV
$26.4M
$1.09M 0.55%
+1
New +$4.54M
QMCO icon
20
Quantum Corp
QMCO
$437M
$696K 0.35%
3,750
+625
+20% +$124K
DTRM
21
DELISTED
Determine, Inc. Common Stock
DTRM
$660K 0.33%
110,080
+76,747
+230% +$452K
WAVX
22
DELISTED
WAVE SYS CORP CL A NEW COM STK (DE)
WAVX
$549K 0.28%
51,228
+6,128
+14% +$79.3K
AAOI icon
23
Applied Optoelectronics
AAOI
$8.04B
$500K 0.25%
+31,000
New +$615K
LIQT icon
24
LiqTech
LIQT
$21.5M
$456K 0.23%
+9,245
New +$491K
III icon
25
Information Services Group
III
$185M
$382K 0.19%
100,400

Similar funds

Goldman Capital Management's Q3 2014 Portfolio in Review

As of Q3 2014, Goldman Capital Management held 35 positions worth $199M, down 1% from $201M the previous quarter. Its ten largest holdings account for 83% of the portfolio.

Goldman Capital Management deployed $6.59M of net new capital in Q3 2014, opening 3 new positions and adding to 15 existing holdings. Its largest new stake was Plus Therapeutics: 1 share worth $1.09M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was FC Global Realty Incorporated Common Stock, an estimated $2.89M trimmed.

  • Goldman Capital Management's largest Q3 2014 buy was Plus Therapeutics: 1 share worth $1.09M.
  • Goldman Capital Management added most to CYREN Ltd. in Q3 2014, an estimated $1.56M increase.
  • Goldman Capital Management's biggest Q3 2014 reduction was FC Global Realty Incorporated Common Stock, cutting an estimated $2.89M.
  • Goldman Capital Management fully exited Sharps Compliance Corp in Q3 2014, selling an estimated $228K.
  • Goldman Capital Management's ten largest holdings make up 83% of its $199M portfolio in Q3 2014.
  • Goldman Capital Management opened 3 new positions and closed 2 in Q3 2014.
  • Goldman Capital Management's portfolio value fell 1% quarter-over-quarter to $199M.

Based on Goldman Capital Management's 13F filing for Q3 2014, filed 12 Nov 2014.